Navigating coverage, coding, and payment is difficult, but it’s particularly complex for in vitro, imaging, and digital diagnostic products. Because diagnostic value relies on measurable changes in the patient treatment pathway as well as outcomes, you need to arrive fully prepared upon launch to prove clinical utility evidence in the target setting of care.
Available in 22 locations around the world, Avania’s market access solutions provide support throughout your product’s life cycle to help you achieve maximum reimbursement potential. Our experts have extensive experience in digital technologies, LDT strategies, coding options, and more to optimize your positioning, coverage, and price.
Download our fact sheet to discover what we can do for your market access strategy.